Table 2. Descriptive analysis of patients’ demographics, response to COS and laboratorial ICSI outcomes in repeated cycles.
Variables r-hCG Trigger (n=18) Dual Trigger (n=18) p-value
Female age (years) 37.83±0.77 38.22±0.77 0.721
Male age (years) 39.06±0.93 39.44±0.93 0.767
Female BMI 24.66±0.58 25.33±0.58 0.414
FSH dose (IU) 2875.00±190.44 2625.00±201.99 0.368
Length of stimulation (days) 10.41±1.33 10.47±1.70 0.911
Length of pituitary suppression (days) 4.76±0.83 4.53±1.23 0.518
Total number of follicles on trigger day 11.17±1.799 10.56±1.80 0.810
Mature follicular rate (%) 46.63±20.30 34.54±21.23 0.095
Estradiol level (pg/mL) 1246.67±261.21 1431.22±301.62 0.644
Number of retrieved oocytes 7.17±1.36 7.72±1.36 0.772
Oocyte yield (%) 60.83±3.18 84.38±3.25 <0.001
MII oocyte rate (%) 59.50±2.44 74.29±3.26 <0.001
MI oocyte rate (%) 18.22±2.63 5.80±2.55 <0.001
PI oocyte rate (%) 16.11±1.34 10.00 ± 0.95 <0.001
Fertilization rate (%) 80.00±2.83 88.12±2.35 0.027
Blastocyst development rate (%) 18.21±1.14 41.67±2.63 <0.001

Note: Retrospective case-control within-subject analysis performed to compare the response to COS and ICSI outcomes in patients who had the first ICSI cycle triggered with r-hCG only and the following ICSI cycle triggered with GnRH agonist and r-hCG. Values are mean ± standard error, unless otherwise noted. COS – controlled ovarian stimulation, ICSI – intracytoplasmic sperm injection, r-hCG – recombinant human chorionic gonadotropin.